2020 American Transplant Congress » Poster Session A: Liver: Immunosuppression and Rejection

Date: Saturday, May 30, 2020

Time: 3:15pm-4:00pm

Location: Virtual

Session Type: Poster Session

Meeting: 2020 American Transplant Congress

3:30pm-4:00pm: Adult Primary Liver Transplant Recipient Outcomes by Immunosuppression Induction Received

T. Shaker¹, G. Larrieux¹, S. Jackson², S. Riad³, T. Pruett¹, T. Leventhal⁴

3:30pm-4:00pm: Comparison of Clinical Outcomes of Induction Regimens in Patients Undergoing Liver Transplantation for Acute Liver Failure

C. M. Anugwom¹, J. Parekh², C. Hwang³, M. MacConmara³, W. M. Lee⁴, T. M. Leventhal¹

3:30pm-4:00pm: Evaluation of Rejection, Infection, and Malignancy Outcomes in Elderly Liver Transplant Recipients Compared to a Younger Cohort

B. Almalki¹, K. Cunningham¹, C. D'Agostino¹, M. Kapugi¹, C. Kane¹, A. Novak¹, D. Ladner², J. Schulte¹

3:30pm-4:00pm: Evaluation of Tacrolimus Dose Requirement in Liver Transplant Recipients from African American Donors Compared to Non-African American Donors

K. Guilbert, I. Plasari, S. Wiehe, F. Gordon

3:30pm-4:00pm: Induction Immunosuppression with Thymoglobulin May Improve Graft Outcomes without Increasing a Risk for Infection in Patients Undergoing Liver Transplantation Alone

M. Henry¹, T. Kitajima², J. Konel¹, S. Yeddula², M. Rizzari², K. Collins², D. Moonka², A. Yoshida², M. Abouljoud², S. Nagai³

3:30pm-4:00pm: Long Term Ursodeoxycholic Acid Use Does Not Alter Long Term Rejection, Biliary Complication, Mortality or Hospitalization Rates after Liver Transplantation

T. Ashraf¹, V. Mendiratta², S. Gill¹, A. Abdelwahab³, D. Moonka², S. Jafri²

3:30pm-4:00pm: Role of Tacrolimus Dose Adjustment at Discontinuation of Fluconazole in Liver Transplant

J. Yau, H. Morris

3:30pm-4:00pm: Single versus Dual Immunosuppression in Liver Transplantation for Autoimmune Liver Diseases

S. Sterling¹, S. Hamel¹, C. Garza¹, I. Feurer², S. Rega², S. Alexopoulos³, M. Izzy⁴

« View all sessions from the 2020 American Transplant Congress